Neuroactive steroids: Their mechanism of action and their function in the stress response

Acta Physiologica Scandinavica

Volumn 167, Issue 3, 1999, Pages 181-188

  Zinder, O ^a,b   Dar, D E ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Chloride channel; GABA(A) receptor; Ion gated channels; Neuroactive steroids; Neurotransmitters; Stress

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 4 AMINOBUTYRIC ACID A RECEPTOR; ALFAXALONE; ANDROGEN; ANDROSTENEDIONE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BICUCULLINE; CALCIMYCIN; CATECHOLAMINE DERIVATIVE; CHLORIDE CHANNEL; DEOXYCORTICOSTERONE; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPNOTIC AGENT; ION CHANNEL; KAINIC ACID; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; OXOTREMORINE M; PILOCARPINE; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE SULFATE; PROGESTERONE; SEDATIVE AGENT; STEROID; VERATRIDINE;

ANXIETY NEUROSIS; BRAIN LEVEL; CATECHOLAMINE SYNTHESIS; CENTRAL NERVOUS SYSTEM; EPILEPSY; HUMAN; INSOMNIA; METABOLITE; NERVE CELL MEMBRANE; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR BINDING; REPOLARIZATION; REVIEW; STEROID BLOOD LEVEL; STEROID METABOLISM; STEROIDOGENESIS; STRESS;

CELL MEMBRANE; DEHYDROEPIANDROSTERONE; DESOXYCORTICOSTERONE; HUMANS; ION CHANNEL GATING; NEUROTRANSMITTER AGENTS; PROGESTERONE; RECEPTORS, GABA; STRESS;

EID: 0033377029     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.1999.00579.x     Document Type: Review

References (68)

1. A receptors in mouse brain. J Neurochem 60, 2212-2216.
2. Arancibia, S., Estupina, C., Pesco, J., Belmar, J. & Tapia-Arancibia, L. 1997. Responsiveness to depolarization under stress and estrous cycle conditions - involvement of GABA-ergic and steroidal interactions. J Neuroscience Res 50, 575-584.
3. Backstrom, T., Gee, K.W., Lan, N., Sorenson, M. & Wahlstrom, G. 1990. Steroids in relation to epilepsy and anesthesia. In: Steroids and Neuronal Activity, Ciba Foundation Symposium, Vol. 153, pp. 225-230. Wiley, NY.
4. Barbaccia, M.L., Roscetti, G., Bolacchi, F. et al. 1996a. Stress induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol Biochem Behav 54, 205-210.
5. A receptor function after acute stress. Neuroendocrinology 63, 166-172.
6. Baulieu, E.E., Robel, P., Vatier, O., Haug, A., Le Goascogne, C. & Bourreau, E. 1987. Neurosteroids: Pregnenolone and Dehydroepiandrosterone in the rat brain. In: K. Fuxe & L.F. Agnati (eds) Receptor-Receptor Interaction, a New Intramembrane Integrative Mechanism, pp. 89-104. Macmillan, London.
7. Bergeron, R., de Montigny, C. & Debonnel, G. 1996. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci 16, 1193-1202.
8. Britton, K.T. & Koob, G.F. 1998. Premenstrual steroids? Nature 392, 869-870.
9. Bullock, A.E., Clark, A.L., Grady, S.R. et al. 1997. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. J Neurochem 68, 2412-2423.
10. Cashin, M.F. & Moravek, V. 1927. The physiological action of cholesterol. Am J Physiol 82, 294-298.
11. Celotti, F., Melcangi, R.C., Negri-Cesi, P. & Ballabio, M. 1987. Differential distribution of the 5-α-reductase in the central nervous system of the rat and the mouse: are the white matter structures of the brain target tissue for testosterone action? J Steroid Biochem 26, 125-129.
12. A receptor activity by alfaxalone. Br J Pharmacol 90, 491-500.
13. Dar, D.E. & Zinder, O. 1998. Short-term effect of steroids on catecholamine secretion from bovine adrenal medulla chromaffin cells. Neuropharmacology 36, 1783-1788.
14. Delaunay, F., Khan, A., Cintra, A. et al. 1997. Pancreatic b-cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 100, 2094-2098.
15. A receptor. Neuroscience 45, 127-135.
16. Edwardson, J.A. & Bennett, G.W. 1974. Modulation of corticotrophin-releasing factor release from hypothalamic synaptosomes. Nature 251, 425-427.
17. Fahey, J.M., Lindquist, D.G., Pritchard, G.A. & Miller, L.G. 1995. Pregnenolone-sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res 669, 183-188.
18. Finn, D.A. & Gee, K.W. 1993. The influence of estrus cycle on neurosteroid potency at the γ-amino-butyric-acid type A receptor complex. J Pharmacol Exptl Ther 265, 1374-1379.
19. Frye, C.A. & Duncan, J.E. 1996. Estradiol benzoate potentiates neuroactive steroids' effects on pain sensitivity. Pharmacol Biochem Behav 53, 27-32.
20. Gasior, M., Carter, R.B. & Witkin, J.M. 1999. Neuroactive steroids: Potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci 10, 107-112.
21. Gazzini, E., Guillon, G., Mouillac, B. & Zingg, H. 1998. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 392, 509-512.
22. A receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation. Mol Pharmacol 40, 995-999.
23. Gyermek, L. & Soyka, L.F. 1975. Steroid Anesthetics. Anesthesiology 42, 331-339.
24. A receptors by neuroactive steroids. Eur J Pharmacol 289, 249-257.
25. Hu, Z., Bourreau, E., Jung-Testas, I., Robel, P. & Bailieu, E. 1987. Neurosteroids: Oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Nat Acad Sci 84, 8215-8219.
26. Johnston, A. & File, S. 1991. Sex differences in animal tests of anxiety. Physiol Behav 49, 245-250.
27. Jung-Testas, I., Hu, Z.Y., Baulieu, E.E. & Robel, P. 1989. Steroid synthesis in rat brain cell cultures. J Steroid Biochem 34, 511-519.
28. Ke, L. & Lukas, R.J. 1996. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J Neurochem 67, 1100-1112.
29. Kokate, T., Cohen, A., Karp, E. & Rogawski, M.L. 1996. Neuroactive steroids protect against pilocarpine and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacol 35, 1049-1056.
30. Krieger, N.R. & Scott, R.G. 1989. Non-neuronal localization for steroid converting enzyme 3-α-hydroxysteroid oxidoreductase in olfactory tubercle of rat brain. J Neurochem 52, 1866-1870.
31. A receptor. Trends Pharmacol Sci 8, 224-227.
32. Lambert, J.J., Hill-Venning, C., Peters, J.A., Sturgess, N.C. & Hales, T.G. 1991. The actions of anaesthetic steroids on inhibitory and excitatory amino acid receptors. In: E. Costa & E. Barnard (eds) FIDIA RF Symposium Series 6, 219-236. Thieme Medical Publishers, New York.
33. Lanthier, A. & Patwardhan, V.V. 1986. Sex steroids and 5-en-3β-hydroxysteroids in specific regions of the human brain and cranial nerves. J Steroid Biochem 25, 445-449.
34. Lawrence, D.K. & Gill, E.W. 1975. Structurally specific effects of some steroid anesthetics on spin labelled liposomes. Mol Pharmacol 11, 280-286.
35. Leb, C.R., Hu, F.Y. & Murphy, B.E. 1997. Metabolism of progesterone by human lymphocytes: Production of neuroactive steroids. J Clin Endoc Metab 82, 4064-4068.
36. A receptor heterogeneity. Nature (Lond) 335, 582-585.
37. Liu, P.-S., Lin, M.-K. & Hsieh, H.-L. 1996. Dehydroepiandrosterone sulfate inhibition of catechoamine secretion from bovine adrenal chromaffin cells. Neuroscience Lett 204, 181-184.
38. Lodge, D. & Anis, N. A. 1984. Effects of ketamine and three other anesthetics on spinal reflexes and inhibitions in the cat. Br J Anaesthesia 56, 1143-1151.
39. Lopez, M.G., Abad, F., Sancho, R. et al. 1991. Membrane-mediated effects of the steroid 17-α-estradiol on adrenal chromaffin release. J Pharmacol Exp Ther 259, 279-285.
40. A receptor channels. Ann Rev Neurosci 17, 569-602.
41. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38, 379-395.
42. Majewska, M.D. & Schwartz, R.D. 1987. Pregnenolone sulfate: an endogenous antagonist of the γ-amino-butyric acid receptor complex in brain? Brain Res 404, 355-360.
43. McEwen, B.S. 1991. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 12, 141-147.
44. McEwen, B.S., Davis, P.G., Parsons, B. & Pfaff, D.W. 1979. The brain as a target for steroid hormone action. Ann Rev Neurosci 2, 65-112.
45. Mellon, S.H. & Deschepper, C.F. 1993. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 629, 283-292.
46. Morrow, A.L., Devaud, L.L., Purdy, R.H. & Paul, S.M. 1995. Neuroactive steroid modulators of the stress response. New York Acad Sci 771, 257-272.
47. Morrow, A.L., Pace, J.R., Purdy, R.H. & Paul, S.M. 1990. Characterization of steroid interactions with γ-amino-butyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol 37, 263-270.
48. A Receptors and Anxiety: From Neurobiology to Treatment, pp. 57-74. Raven Press, NY.
49. A receptors. FASEB J 4, 1469-1480.
50. Patchev, V.K., Shoaib, M., Holsboer, F. & Almeida, F.X. 1994. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin releasing hormone in the rat hypothalamus, Neuroscience 62, 265-271.
51. Paul, S.M. & Purdy, R.H. 1992. Neuroactive Steroids. FASEB J 6, 2311-2322.
52. A receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 94, 1257-1269.
53. Picard, D. 1998. Steroids tickle cells inside and out. Nature 392, 437-438.
54. Pietras, R.J. & Szego, C.M. 1975. Endometrial cell calcium and estrogen action. Nature 265, 357-359.
55. Prince, R.J. & Simmonds, M.A. 1992. Steroid modulation of the strychnine-sensitive glycine receptor. Neuropharmacology 31, 201-205.
56. Purdy, R.H., Morrow, A.L., Moore, P.H. & Paul, S.M. 1991. Stress-induced elevations of gamma-amino-butyric-acid type A receptor-active steroids in the rat brain. Proc Nat Acad Sci 88, 4553-4557.
57. Selye, H. 1941. The anaesthetic effect of steroid hormones. Proc Soc Exp Biol Med 46, 116-121.
58. Selye, H. 1942. Correlations between the chemical structure and the pharmacological actions of steroids. Endocrinology 30, 437-543.
59. Spach, C. & Streeten, D.H. 1964. Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterone, in vitro. J Clin Invest 43, 217-227.
60. Turner, D.M., Ransom, R.W., Yang, J.S. & Olsen, R.W. 1989. Steroid anesthetics and naturally occurring analogs modulate the γ-amino-butyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther 248, 960-966.
61. A receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J Physiol (Lond) 456, 215-245.
62. Uki, M., Nabekura, J. & Akaike, N. 1999. Suppression of the nicotinic acetylcholine response in rat superior cervical ganglionic neurons by steroids. J Neurochem 72, 808-814.
63. Valera, S., Ballivet, M. & Bertrand, D. 1992. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Nat Acad Sci 89, 9949-9953.
64. 2+ in Xenopuslaevis oocytes. Proc Nat Acad Sci USA 77, 1534-1536.
65. Wehling, M. 1997. Specific, nongenomic actions of steroid hormones. Ann Rev Physiol 59, 365-393.
66. Wehling, M., Neylon, C.B., Fullerton, M., Bobik, M. & Funder, J.W. 1995. Non-genomic effects of aldosterone on intracellular calcium in vascular smooth muscle cells. Circ Res 76, 973-979.
67. Wu, F.S., Gibbs, T.T. & Farb, D.H. 1990. Inverse modulation of γ-amino-butyric acid and glycine-induced currents by progesterone. Mol Pharmacol 37, 597-602.
68. Wu, F.S., Gibbs, T.T. & Farb, D.H. 1991. Pregnenolone-sulfate: A positive allosteric modulator of the NMDA receptor. Mol Pharmacol 40, 333-336.